Plain-English translation of NCT06485895 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new blood test called an IGRA test to see how accurately it can identify people with active tuberculosis disease or latent tuberculosis infection. The study will include 500 patients who are already undergoing tuberculosis screening. The goal is to confirm that this blood test is reliable and can help doctors diagnose tuberculosis more effectively.
Current methods for diagnosing tuberculosis have limitations, and researchers want to validate whether this new blood test can accurately and consistently identify both active disease and latent infection. Better diagnostic tools can help catch tuberculosis earlier and improve patient care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a blood test (the IGRA test) taken as part of your routine tuberculosis screening. Your blood sample will be used to evaluate how well the test performs at detecting tuberculosis. The study does not require multiple visits or long-term follow-up — participation involves the testing that you are already undergoing or planning to undergo as part of your medical care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France
Sponsor
Assistance Publique Hopitaux De Marseille
Enrollment target
~500 participants
Started
July 2024
Primary completion
July 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
PR PIERRE EDOUARD FOURNIER PU-PH
ASSISTANCE PUBLIQUE HOPITAUX D EMARSEILLE
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.